Loading your page…
Marketing-authorisation holder · Spain
96 medicines in 1 country, as authorisation holder and marketer.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
1–25 of 96
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTIMAG 400 MG/ML SOLUCION ORAL40 g · Solución oral | Pidolato | Spain | Marketed | 1984 |
| ALERGICAL 0,5 mg/ 0,1mg/g CREMA0,1 mg + 0,5 mg · Crema | Fluocinolone acetonide, Betamethasone | Spain | Marketed | 1973 |
| ANALGILASA 500 mg /30 mg/ 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA500 mg + 30 mg + 10 mg · Comprimido recubierto con película | Paracetamol, Caffeine, Codeine | Spain | Marketed | 1969 |
| ANALGIPLUS 500 mg/30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA500 mg + 30 mg · Comprimido recubierto con película | Paracetamol, Codeine | Spain | Marketed | 2000 |
| ASTRILAX 20 MG COMPRIMIDOS20 mg · Comprimido | Bilastine | Spain | Marketed | 2025 |
| ASTRILAX FLAS 20 MG COMPRIMIDOS BUCODISPERSABLES20 mg · Comprimido bucodispersable | Bilastine | Spain | Marketed | 2025 |
| AZZAVIX 1000 MG COMPRIMIDOS GASTRORRESISTENTES1000 mg · Comprimido gastrorresistente | Mesalazine | Spain | Authorised | 2021 |
| AZZAVIX 1500 MG COMPRIMIDOS GASTRORRESISTENTES1500 mg · Comprimido gastrorresistente | Mesalazine | Spain | Authorised | 2026 |
| AZZAVIX 500 MG COMPRIMIDOS GASTRORRESISTENTES500 mg · Comprimido gastrorresistente | Mesalazine | Spain | Authorised | 2020 |
| BILAXTEN 12 MG/ML SOLUCIÓN INYECTABLE12 mg/ml · Solución inyectable | Bilastine | Spain | Authorised | 2025 |
| BILAXTEN 2,5 MG/ML SOLUCION ORAL2,5 mg · Solución oral | Bilastine | Spain | Marketed | 2017 |
| BILAXTEN 20 mg COMPRIMIDOS20 mg · Comprimido | Bilastine | Spain | Marketed | 2010 |
| BILAXTEN 6 MG/ML COLIRIO EN SOLUCION6 mg/ml · Colirio en solución | Bilastine | Spain | Marketed | 2022 |
| BILAXTEN FLAS 10 MG COMPRIMIDOS BUCODISPERSABLES10 mg · Comprimido bucodispersable | Bilastine | Spain | Marketed | 2017 |
| BILAXTEN FLAS 20 MG COMPRIMIDOS BUCODISPERSABLES20 mg · Comprimido bucodispersable | Bilastine | Spain | Marketed | 2023 |
| BLENIX 1.000 MG COMPRIMIDOS GASTRORRESISTENTES500 mg · Comprimido gastrorresistente | Mesalazine | Spain | Authorised | 2023 |
| BLENIX 1500 MG COMPRIMIDOS GASTRORRESISTENTES1500 mg · Comprimido gastrorresistente | Mesalazine | Spain | Authorised | 2026 |
| BLENIX 500 MG COMPRIMIDOS GASTRORRESISTENTES500 mg · Comprimido gastrorresistente | Mesalazine | Spain | Authorised | 2023 |
| BRONQUIDIAZINA CR SUSPENSIÓN ORAL400 mg + 4 mg + 80 mg + 32,5 mg · Suspensión oral | Sulfamethoxazole, Bromhexine, Trimethoprim, Balsamo tolu exto fluido | Spain | Marketed | 1977 |
| CITICOLINA FAES 1000 MG SOLUCION ORAL EFG1045 mg · Solución oral | Citicolina | Spain | Marketed | 2018 |
| CLAVERSAL 1 G COMPRIMIDOS GASTRORRESISTENTES1000 mg · Comprimido gastrorresistente | Mesalazine | Spain | Marketed | 2018 |
| CLAVERSAL 500 mg COMPRIMIDOS GASTRORRESISTENTES500 mg · Comprimido gastrorresistente | Mesalazine | Spain | Marketed | 1988 |
| CLAVERSAL 500 mg SUPOSITORIOS500 mg · Supositorio | Mesalazine | Spain | Marketed | 1995 |
| CLAVERSAL ESPUMA RECTAL1,066 g · Espuma rectal | Mesalazine | Spain | Marketed | 1997 |
| DEFAL 30 MG COMPRIMIDOS EFG30,00 mg · Comprimido | Deflazacort | Spain | Marketed | 2008 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 96 | 83 | 13 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.
